These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 11661977)

  • 1. The NIH Guidelines for recombinant DNA research and the authority of FDA to require compliance with the Guidelines.
    Korwek EL
    Food Drug Cosmet Law J; 1980 Nov; 35(11):633-50. PubMed ID: 11661977
    [No Abstract]   [Full Text] [Related]  

  • 2. Introduction to recombinant DNA research, development and evolution of the NIH guidelines, and proposed legislation.
    Talbot B
    Univ Toledo Law Rev; 1981; 12(4):804-14. PubMed ID: 11649587
    [No Abstract]   [Full Text] [Related]  

  • 3. Regulation of genetic engineering: less concern about Frankensteins but time for action on commercial production.
    Karny GM
    Univ Toledo Law Rev; 1981; 12(4):815-68. PubMed ID: 11649588
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulating biotechnology.
    McGarity TO
    Issues Sci Technol; 1985; 1(3):40-56. PubMed ID: 11649701
    [No Abstract]   [Full Text] [Related]  

  • 5. Corporate responsibility for recombinant DNA activities.
    Berger BA
    Univ Toledo Law Rev; 1981; 12(4):913-24. PubMed ID: 11649592
    [No Abstract]   [Full Text] [Related]  

  • 6. Perspectives on the FDA status of drug products manufactured by the recombinant DNA technique.
    Korwek EL; Trinker DS
    Food Drug Cosmet Law J; 1981 Oct; 36(10):517-35. PubMed ID: 11650658
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of the Human Genome Project at the interface between patent and FDA laws.
    Cunningham BC
    Risk; 1996; 7(3):253-66. PubMed ID: 11655078
    [No Abstract]   [Full Text] [Related]  

  • 8. Recombinant DNA: a case study in regulation of scientific research.
    Chalfant JC; Hartmann ME; Blakeboro A
    Ecol Law Q; 1979; 8(1):55-129. PubMed ID: 11665069
    [No Abstract]   [Full Text] [Related]  

  • 9. Recombinant DNA guidelines wear thin: NIH moves to voluntary regulation.
    Dickson D
    Nature; 1981 May; 29(5810):3. PubMed ID: 11661933
    [No Abstract]   [Full Text] [Related]  

  • 10. Regulating genetic engineering in an era of increased judicial deference: a proper balance of the federal powers.
    Von Oehsen WH
    Adm Law Rev; 1988; 40(3):303-44. PubMed ID: 11650827
    [No Abstract]   [Full Text] [Related]  

  • 11. DNA: have the corporations already grabbed control of new life forms?
    Rifkin J
    Mother Jones; 1977; 2(2):23-39. PubMed ID: 11649384
    [No Abstract]   [Full Text] [Related]  

  • 12. The regulation of recombinant DNA research: the alternative of local control.
    Rosenblatt DP
    Boston Coll Environ Aff Law Rev; 1982; 10(1):37-78. PubMed ID: 11649694
    [No Abstract]   [Full Text] [Related]  

  • 13. The great 'recombinant DNA' controversy and the need for public debate.
    Pearson M
    Sci Forum; 1977 Jun; 10(3):3-4+. PubMed ID: 11650574
    [No Abstract]   [Full Text] [Related]  

  • 14. You shall be as gods.
    Powledge TM
    Worldview; 1977 Sep; 20(9):45-7. PubMed ID: 11661489
    [No Abstract]   [Full Text] [Related]  

  • 15. Summary and critique of the new NIH guidelines for recombinant DNA research.
    Szybalski W
    Gene; 1979; 5():179-181+. PubMed ID: 11660940
    [No Abstract]   [Full Text] [Related]  

  • 16. US biological weapons: new test facility defended.
    Palca J
    Nature; 1986 Jun; 321(6073):805. PubMed ID: 11645772
    [No Abstract]   [Full Text] [Related]  

  • 17. Rules to protect drug-test participants via follow-up exams are slated by FDA.
    Spivak J
    Wall St J (East Ed); 1976 Mar; ():5. PubMed ID: 11649042
    [No Abstract]   [Full Text] [Related]  

  • 18. Scientists ask Congress to control DNA research.
    Leeper EM
    Bioscience; 1977 Feb; 27(2):141-3. PubMed ID: 11661597
    [No Abstract]   [Full Text] [Related]  

  • 19. Biotechnology: can a new technology survive?
    Withers WW; Kenworthy PG
    St Louis Univ Law J; 1987; 31(3):673-97. PubMed ID: 11650845
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of vaccines to meet public health needs: incentives and obstacles.
    Russell PK
    Risk; 1996; 7(3):239-52. PubMed ID: 11655077
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.